Evaluation of Clinical Outcomes and Toxicities in Multiple Myeloma Patients Receiving Commercial Talquetamab

被引：0

作者：

Lu, Rebecca ^{[1
]}

Chen, Jessica ^{[1
]}

Ow, Karla ^{[1
]}

Hildebrandt, Michelle ^{[1
]}

Huen, Auris ^{[1
]}

Cardoso, Richard ^{[1
]}

Chambers, Mark ^{[1
]}

Abreu, Michelly ^{[1
]}

Cuellar, Elizabeth ^{[1
]}

Ighovoyivwi, Efe ^{[1
]}

Knight, Sarah ^{[1
]}

Santiago, Minifrida ^{[1
]}

Savoie, Cecilia ^{[1
]}

Varghese, Jaimole ^{[1
]}

Zachariah, Annie ^{[1
]}

Becnel, Melody ^{[1
]}

Gaballa, Mahmoud ^{[1
]}

Orlowski, Robert ^{[1
]}

Patel, Krina ^{[1
]}

Pasvolsky, Oren ^{[1
]}

Thomas, Sheeba ^{[1
]}

Ye, Jing Christine ^{[1
]}

Weber, Donna ^{[1
]}

Lee, Hans ^{[1
]}

Richards, Tiffany ^{[1
]}

机构：

[1] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA

来源：

CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2024年 / 24卷

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

NSO-04

引用

页码：S281 / S281

页数：1

共 50 条

[31] Clinical Outcomes of Subsequent Therapies in Patients with Relapsed/Refractory Multiple Myeloma Following Talquetamab Treatment: Analyses from the Phase 1/2 MonumenTAL-1 Study
Sanchez, Larysa
Schinke, Carolina
Krishnan, Amrita
Berdeja, Jesus G.
de Donk, Niels W. C. J. van
Mateos, Maria Victoria
Chari, Ajai
Parekh, Samir
Mouhieddine, Tarek H.
Jagannath, Sundar
Bahlis, Nizar J.
Touzeau, Cyrille
Oriol, Albert
San-Miguel, Jesus
Otero, Paula Rodriguez
Minnema, Monique C.
Campagna, Michela
Masterson, Tara J.
Hilder, Brandi W.
Tolbert, Jaszianne
Renaud, Thomas
Gray, Kathleen
Smit, Damiette
Heuck, Christoph
Rasche, Leo
BLOOD, 2023, 142
[32] Longitudinal changes in echocardiographic variables and endothelial function to predict cardiovascular toxicities in patients with multiple myeloma receiving carfilzomib
Johnston, Hannah
Prabhu, Nicole
Cunningham, Claire
Cooperrider, Jennifer H.
Andreatos, Evangelia
Gorski, Martha
Major, Sarah
Wolfe, Brittany
Kruse, Eric
Derman, Benjamin Avi
Lang, Roberto
Jakubowiak, Andrzej
Major, Ajay
DeCara, Jeanne
JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
[33] Clinical outcomes with intensive therapy for patients with primary resistant multiple myeloma
Alexanian, R
Weber, D
Delasalle, K
Handy, B
Champlin, R
Giralt, S
BONE MARROW TRANSPLANTATION, 2004, 34 (03) : 229 - 234
[34] Impact of Beta Blocker on Clinical Outcomes of Multiple Myeloma (MM) Patients
Hwa, Yi Lisa
Lacy, Martha Q.
Gertz, Morie A.
Buadi, Francis
Rajkumar, S. Vincent
Kumar, Shaji
Kapoor, Prashant
Go, Ronald S.
Hayman, Suzanne R.
Lin, Yi
Lust, John A.
Dingli, David
Russell, Stephen J.
Gonsalves, Wilson I.
Dispenzieri, Angela
BLOOD, 2014, 124 (21)
[35] Clinical outcomes with intensive therapy for patients with primary resistant multiple myeloma
R Alexanian
D Weber
K Delasalle
B Handy
R Champlin
S Giralt
Bone Marrow Transplantation, 2004, 34 : 229 - 234
[36] Clinical outcomes of venous thromboembolism with dalteparin therapy in multiple myeloma patients
Lee, Sung-Eun
Jeon, Young-Woo
Yoon, Jae-Ho
Cho, Byung-Sik
Eom, Ki-Seong
Kim, Yoo-Jin
Kim, Hee-Je
Lee, Seok
Cho, Seok-Goo
Kim, Dong-Wook
Lee, Jong Wook
Min, Woo-Sung
Kim, Myungshin
Min, Chang-Ki
THROMBOSIS RESEARCH, 2015, 136 (05) : 974 - 979
[37] Duration of frontline therapy and impact on clinical outcomes in newly diagnosed multiple myeloma patients not receiving frontline stem cell transplant
Ailawadhi, Sikander
Ogbonnaya, Augustina
Murty, Sharanya
Cherepanov, Dasha
Schroader, Bridgette Kanz
Romanus, Dorothy
Farrelly, Eileen
Chari, Ajai
CANCER MEDICINE, 2023, 12 (03): : 3145 - 3159
[38] Prevalent Treatment Patterns of Teclistamab and Talquetamab for Multiple Myeloma (MM): Experience from 609 Patients
Chunara, Farheen
Shah, Mansi R.
Shah, Nishi
Kent, Jessica
Mohyuddin, Ghulam Rehman
Radhakrishnan, Sabarinath, V
Kaur, Gurbakhash
Chakraborty, Rajshekhar
Rasche, Leo
Schinke, Carolina
D'Souza, Anita
Szabo, Aniko
Mohan, Meera
BLOOD, 2024, 144 : 2395 - 2395
[39] Survival outcomes of patients receiving thalidomide-dexamethasone for previously untreated multiple myeloma.
Thomas, Sheeba K.
Giralt, Sergio A.
Wang, Michael
Delasalle, Kay B.
Gavino, Maria
Rankin, Kim
Alexanian, Raymond
Weber, Donna M.
BLOOD, 2006, 108 (11) : 1019A - 1019A
[40] Infectious toxicities in patients treated with bispecific antibodies in multiple myeloma
Saez, Adolfo
Lopez-Munoz, Nieves
Maria Sanchez-Pina, Jose
Alonso, Rafael
Cuellar, Clara
Lazaro, Paula
Jimenez Ubieto, Ana
Calbacho, Maria
Martinez Lopez, Joaquin
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022, 22 : S97 - S98

← 1 2 3 4 5 →